CAMP4 Therapeutics (NASDAQ:CAMP) CEO Buys 6,551 Shares of Stock

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) CEO Josh Mandel-Brehm acquired 6,551 shares of the stock in a transaction dated Monday, August 3rd. The shares were bought at an average price of $1.65 per share, with a total value of $10,809.15. Following the completion of the purchase, the chief executive officer directly owned 284,968 shares of the company’s stock, valued at approximately $470,197.20. This trade represents a 2.35% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.

CAMP4 Therapeutics Stock Down 3.6%

Shares of CAMP traded down $0.15 during trading hours on Wednesday, reaching $4.01. 86,050 shares of the company traded hands, compared to its average volume of 176,472. The business has a fifty day moving average price of $4.02 and a 200-day moving average price of $4.31. CAMP4 Therapeutics Corporation has a 12-month low of $1.32 and a 12-month high of $7.75. The stock has a market capitalization of $208.24 million, a P/E ratio of -1.70 and a beta of 0.22.

CAMP4 Therapeutics (NASDAQ:CAMP) last issued its quarterly earnings results on Thursday, May 7th. The Wireless communications provider reported ($0.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.11). The firm had revenue of $1.29 million for the quarter. CAMP4 Therapeutics had a negative return on equity of 194.74% and a negative net margin of 2,193.72%. As a group, research analysts predict that CAMP4 Therapeutics Corporation will post -0.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. China Universal Asset Management Co. Ltd. acquired a new position in CAMP4 Therapeutics in the fourth quarter valued at approximately $61,000. Jefferies Financial Group Inc. purchased a new position in shares of CAMP4 Therapeutics during the 4th quarter valued at approximately $70,000. State Street Corp increased its holdings in shares of CAMP4 Therapeutics by 52.7% during the 4th quarter. State Street Corp now owns 39,700 shares of the Wireless communications provider’s stock valued at $243,000 after purchasing an additional 13,700 shares in the last quarter. Bank of America Corp DE acquired a new position in shares of CAMP4 Therapeutics in the 4th quarter valued at $86,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in CAMP4 Therapeutics during the fourth quarter worth $115,000.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Zacks Research lowered CAMP4 Therapeutics from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. raised shares of CAMP4 Therapeutics from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $5.00 to $9.00 in a research report on Tuesday, June 16th. Rodman & Renshaw started coverage on shares of CAMP4 Therapeutics in a research note on Tuesday, April 14th. They set a “buy” rating and a $7.00 price objective for the company. Weiss Ratings downgraded shares of CAMP4 Therapeutics from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 21st. Finally, Chardan Capital set a $6.50 price objective on shares of CAMP4 Therapeutics and gave the stock a “buy” rating in a research note on Wednesday, June 10th. Seven research analysts have rated the stock with a Buy rating and two have given a Sell rating to the stock. According to data from MarketBeat, CAMP4 Therapeutics has a consensus rating of “Moderate Buy” and a consensus target price of $8.36.

CAMP4 Therapeutics Company Profile

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.